Epidemiology of Community-Acquired Pneumonia Hospitalizations and Associated Complications Before and After the Implementation of the Heptavalent Pneumococcal Conjugate Vaccine in Athens, Greece

J Pediatric Infect Dis Soc. 2015 Sep;4(3):260-3. doi: 10.1093/jpids/pit088. Epub 2014 Jan 15.

Abstract

We determined the rates of community-acquired pneumonia (CAP)-associated hospitalizations and complications in Athens, over a period covering 4 years before and 4 years after the implementation of the 7-valent pneumococcal vaccine (PCV7) in Greece. PCV7 had no impact on pediatric CAP rates, whereas there was an increase in CAP-associated complications.

Keywords: children; pneumococcal vaccine; pneumonia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Child, Preschool
  • Community-Acquired Infections / epidemiology*
  • Community-Acquired Infections / prevention & control
  • Diagnostic Tests, Routine
  • Greece
  • Heptavalent Pneumococcal Conjugate Vaccine / administration & dosage*
  • Heptavalent Pneumococcal Conjugate Vaccine / immunology
  • Humans
  • Immunogenicity, Vaccine
  • Infant
  • Infant, Newborn
  • Pneumococcal Infections / epidemiology*
  • Pneumococcal Infections / immunology
  • Pneumococcal Infections / prevention & control*
  • Pneumonia / epidemiology*
  • Pneumonia / prevention & control
  • Retrospective Studies
  • Tertiary Care Centers

Substances

  • Heptavalent Pneumococcal Conjugate Vaccine